The 36-month beta value for SLXN is at -0.22.
The public float for SLXN is 1.66M, and currently, shorts hold a 9.87% of that float. The average trading volume for SLXN on October 22, 2024 was 2.40M shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
SLXN) stock’s latest price update
Silexion Therapeutics Corp (NASDAQ: SLXN) has seen a decline in its stock price by -8.97 in relation to its previous close of 0.37. However, the company has experienced a 13.33% gain in its stock price over the last five trading sessions. businesswire.com reported 2024-10-01 that GRAND CAYMAN, Cayman Island–(BUSINESS WIRE)—- $SLXN #BioTech–Silexion Therapeutics Corp. (NASDAQ: SLXN) (“Silexion” or the “Company”), a clinical-stage biotech developing RNA interference (RNAi) therapies for KRAS-driven cancers, today announced new preclinical findings for SIL-204, its second-generation siRNA candidate, following the optimization of its extended-release formulation. These latest findings demonstrate that the latest SIL-204-microparticle formulation can inhibit the growth and induce necrosis.
SLXN’s Market Performance
Silexion Therapeutics Corp (SLXN) has experienced a 13.33% rise in stock performance for the past week, with a -61.39% drop in the past month, and a -97.17% drop in the past quarter. The volatility ratio for the week is 15.06%, and the volatility levels for the past 30 days are at 17.96% for SLXN. The simple moving average for the past 20 days is -23.69% for SLXN’s stock, with a -96.06% simple moving average for the past 200 days.
SLXN Trading at -80.08% from the 50-Day Moving Average
After a stumble in the market that brought SLXN to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -97.52% of loss for the given period.
Volatility was left at 17.96%, however, over the last 30 days, the volatility rate increased by 15.06%, as shares sank -56.39% for the moving average over the last 20 days.
During the last 5 trading sessions, SLXN rose by +13.33%, in comparison to the 20-day moving average, which settled at $0.4402. In addition, Silexion Therapeutics Corp saw -96.90% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for SLXN
Equity return is now at value -3.78, with -3.13 for asset returns.
The liquidity ratio also appears to be rather interesting for investors as it stands at 1.75.
Conclusion
In conclusion, Silexion Therapeutics Corp (SLXN) has had a bad performance lately. Opinion on the stock among analysts is mixed, with some giving it a “buy” rating and others a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
